Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352
CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the…
CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the…
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…
Data from Animal Studies on TNX-1700 (recombinant TFF2 – albumin fusion peptide) in Syngeneic Models…
Data from Animal Studies on TNX-1700 (recombinant TFF2 – albumin fusion peptide) in Syngeneic Models…
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) — Proxygen, a leader in the discovery and…
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) — Proxygen, a leader in the discovery and…
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s…
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s…
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
International Biopharma Executive Brings Nearly Twenty Years of Financial and Strategic Experience CAMBRIDGE, Mass., April…
International Biopharma Executive Brings Nearly Twenty Years of Financial and Strategic Experience CAMBRIDGE, Mass., April…
BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology…
BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology…
Top-line data from CHAPTER-1, a proof-of-concept Phase 2 study of PHVS416 for the prophylactic treatment…
Top-line data from CHAPTER-1, a proof-of-concept Phase 2 study of PHVS416 for the prophylactic treatment…
New code is expected to advance commercialization efforts in doctors’ offices and other outpatient settings…
New code is expected to advance commercialization efforts in doctors’ offices and other outpatient settings…
WOODCLIFF LAKE, N.J., April 05, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…